Consensus Guidelines for the Treatment of Atopic Dermatitis in Korea (Part II): Systemic Treatment
- Authors
- Kim, Jung Eun; Kim, Hyun Jeong; Lew, Bark-Lynn; Lee, Kyung Ho; Hong, Seung Phil; Jang, Yong Hyun; Park, Kui Young; Seo, Seong Jun; Bae, Jung Min; Choi, Eung Ho; Suhr, Ki Beom; Lee, Seung Chul; Ko, Hyun Chang; Park, Young Lip; Son, Sang Wook; Seo, Young Jun; Lee, Yang Won; Cho, Sang Hyun; Park, Chun Wook; Roh, Joo Young
- Issue Date
- Oct-2015
- Publisher
- 대한피부과학회
- Keywords
- Administration; oral; Dermatitis; Guideline; Korea; Therapeutics
- Citation
- Annals of Dermatology, v.27, no.5, pp 578 - 592
- Pages
- 15
- Journal Title
- Annals of Dermatology
- Volume
- 27
- Number
- 5
- Start Page
- 578
- End Page
- 592
- URI
- https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/10269
- DOI
- 10.5021/ad.2015.27.5.578
- ISSN
- 1013-9087
2005-3894
- Abstract
- Background: Since the treatment guidelines for atopic dermatitis (AD) were issued by the Korean Atopic Dermatitis Association (KADA) work group in 2006, there have been further advances in the systemic treatment of AD. Objective: We aimed to establish updated.evidence- and experience-based systemic treatment guidelines for Korean AD. Methods: We compiled a database of references from relevant systematic reviews and guidelines regarding the systemic management of AD, including antihistamines, antimicrobials, systemic immunomodulators, allergen-specific immunotherapy, phototherapy, adjunctive treatment, and complementary and alternative medicines. Evidence for eath statement was graded and classified based on the strength of the recommendation. Thirty-nine council members of KADA participated in the three rounds of votes and expert consensus recommendations were established. Results: The use of antihistamines is recommended to relieve pruritus and to prevent exacerbation due to scratching in AD patients. Infection should be controlled as needed and long-term medication should be avoided. For moderate to severe AD patients, concomitant active treatments with systemic immunomodulators are indicated. Cyclosporine is the first choice among systemic immunomodulators and others should be considered as second-line alternatives. Allergen-specific immunotherapy could be effective in AD patients with aeroallergen hypersensitivity. Phototherapy can be useful for moderate to severe AD patients and narrowband ultraviolet B is the most effective option. Complementary and alternative medicines cannot be recommended for treating AD. Conclusion: We expect these recommendations to be a reference guide for physicians and AD patients in choosing the appropriate treatment to improve quality of life and decrease unnecessary social medical costs.
- Files in This Item
- There are no files associated with this item.
- Appears in
Collections - College of Medicine > Department of Dermatology > 1. Journal Articles
![qrcode](https://api.qrserver.com/v1/create-qr-code/?size=55x55&data=https://scholarworks.bwise.kr/sch/handle/2021.sw.sch/10269)
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.